Actinogen

Actinogen

A biotechnology company engaged in commercialising bioactive compounds.
References in periodicals archive ?
M2 PHARMA-November 27, 2018-Australia's Actinogen Medical enrols final patient into XanADu trial
M2 EQUITYBITES-November 27, 2018-Australia's Actinogen Medical enrols final patient into XanADu trial
Australian biotech company Actinogen Medical (ASX:ACW) revealed on Sunday that it has admitted the final patient under its Phase II XanADu clinical trial of Xanamem for the treatment of mild Alzheimer's disease.
Australian company Actinogen Medical says Alzheimer's is Australia's second biggest killer.
We then reverse merged it into an Australian cash shell, Actinogen, thereby giving the asset access to $3m of capital, which will be enough to take it to phase two trials.
27 August 2014 - Australia-based biotechnology firm Actinogen Ltd (ASX:ACW) announced today it had signed an agreement to acquire UK Alzheimer's dementia therapies developer Corticrine Ltd.
Swansea University is pioneering Europe's five-year multi-million pound ActinoGEN project to find solutions to drug-resistant diseases.
The five-year ActinoGen project has attracted e9.4m (pounds 6.4m) of European Union funding.
Experts from across Europe were at the University of Wales, Swansea yesterday to officially start the five-year multi-million-pound ActinoGEN project.
Australia-based biotechnology firm Actinogen Ltd (ASX:ACW) announced it had signed an agreement to acquire UK Alzheimer's dementia therapies developer Corticrine Ltd.
The meeting this weekend will mark the start of a five-year 9.4 million euro European Union-funded research project, called ActinoGEN.
- Australia-based Actinogen Medical (ASX: ACW) has enrolled the final patient into XanADu, its Phase II clinical trial of Xanamem in the treatment of patients with mild Alzheimer's disease, the company said.